Moreover, individuals with GBM frequently manifest systemic immunosuppression, characterized by the inhibition of activation of T cells through the IL-10-TGF-β pathway following DCs activation at the deep cervical lymph nodes [5]. This evidence concerns the gene TGFB1 and glioblastoma.